Meet Dr Robert Mamoun CEO/CSO of Ciloa BioFIT 2014, the  Pharma and Biotech Event in Lille (France) on December 2-3, 2014.

Schedule for One-on-One partnering event dedicated to tech transfer and open innovation in the Life Sciences sector.

Ciloa technology allows getting  fully native and mature membrane proteins (GPCRs, Kinase Receptors, Ion channels, viral proteins, etc.) out of cells on small vesicles called exosomes.These recombinant exosomes combine perfect antigen with natural adjuvant function allowing to develop therapeutic and preventive vaccines and also therapeutic monoclonal antibodies. The applications concern all the domains of human and animal health (cancers, cardiopathologies, diabetes, neuro-pathologies, infectious diseases…).